Is PTGX Stock A Buy or Sell?
In this article you are going to find out whether hedge funds think Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is a good investment right now.
Protagonist Therapeutics Inc (PTGX)
Market is closed
News
- First
- << Previous
- 11 - 20
Is PTGX A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Protagonist Therapeutics, Inc. (PTGX): Are Hedge Funds Right About This Stock?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here is What Hedge Funds Think About Protagonist Therapeutics, Inc. (PTGX)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Here's What Hedge Funds Think About Protagonist Therapeutics, Inc. (PTGX)
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31...
Market Movers Today: Biohaven Pharmaceutical Holding Co Ltd (BHVN), Facebook, Inc. (FB), Longfin Corp (LFIN), Verona Pharma PLC - ADR (VRNA), and More
Biohaven Pharmaceutical Holding Co. Ltd.
13G Filing: Adage Capital Management and Protagonist Therapeutics Inc (PTGX)
Adage Capital Partners GP, L.L.C., a limited liability company organized under the laws of the State of Delaware ("ACPGP"), as general partner of ACP with respect to the shares of Common Stock directly...
Wondering What's Happening in the Financial Markets Today? Check Out These 31 Stories!
"U.S. stocks edged lower on Tuesday as weakness in the energy and financial sectors outweighed gains in technology shares.
Protagonist Therapeutics Inc (PTGX): RA Capital Management Acquires 6.8% Stake
Peter Kolchinsky's RA Capital Management reported via a recent 13G filing with the SEC that it has taken a new position in a company that has recently gone public, Protagonist Therapeutics Inc (NASDAQ...
Protagonist Therapeutics Inc (PTGX): Adage Capital Management Reveals 9.69% Stake
Phil Gross (pictured below) and Robert Atchinson's Adage Capital Management recently made a new addition to its portfolio, initiating a position in Protagonist Therapeutics Inc (NASDAQ:PTGX), which ...
- First
- << Previous
- 11 - 20
Billionaire Hedge Funds
